Cancer Pharmacology Research Program

Program Leaders: X. F. Steven Zheng, PhD and Stephen K. Burley, MD, DPhil

Overall Goals:

To discover and develop more effective cancer treatments through pharmacology-based preclinical research. The guiding principal is that a fundamental understanding of the biology of molecular targets in cancer is key for discovering and developing innovative therapeutic strategies and for overcoming drug resistance.

Specific Aims:

  • To understand the biology of key molecular targets in cancer that drive cell growth, proliferation, and survival so that they can be effectively targeted for cancer therapy.
  • To determine the modes of action and mechanisms of resistance to anticancer agents. 
  • To discover and develop novel therapeutics and drug delivery technologies for more effective cancer treatment. 

Collaborating Research Programs:

Useful Links:


image that says give now and support cancer research with link to giving page





Robert Wood Johnson Barnabas Health logo with link to Partners page





ScreenNJ logo with link to website






Big Ten Cancer Research Consortium





Rutgers Health